6-hydroxydopa has been researched along with Leukemia L 1210 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cohen, G; Morrison, ME; Yagi, MJ | 1 |
1 other study(ies) available for 6-hydroxydopa and Leukemia L 1210
Article | Year |
---|---|
In vitro studies of 2,4-dihydroxyphenylalanine, a prodrug targeted against malignant melanoma cells.
Topics: Animals; Cell Survival; Cells, Cultured; Dihydroxyphenylalanine; Leukemia L1210; Mammary Neoplasms, Experimental; Melanoma; Mice; Monophenol Monooxygenase | 1985 |